161 related articles for article (PubMed ID: 37816208)
1. Axillary Treatment and Chronic Breast Cancer-Related Lymphedema: Implications for Prospective Surveillance and Intervention From a Randomized Controlled Trial.
Boyages J; Vicini FA; Manavi BA; Gaw RL; Koelmeyer LA; Ridner SH; Shah C
JCO Oncol Pract; 2023 Dec; 19(12):1116-1124. PubMed ID: 37816208
[TBL] [Abstract][Full Text] [Related]
2. The Risk of Subclinical Breast Cancer-Related Lymphedema by the Extent of Axillary Surgery and Regional Node Irradiation: A Randomized Controlled Trial.
Boyages J; Vicini FA; Shah C; Koelmeyer LA; Nelms JA; Ridner SH
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(4):987-997. PubMed ID: 33127493
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of Bioimpedance Spectroscopy or Tape Measure Triggered Compression Intervention in Chronic Breast Cancer Lymphedema Prevention.
Ridner SH; Dietrich MS; Boyages J; Koelmeyer L; Elder E; Hughes TM; French J; Ngui N; Hsu J; Abramson VG; Moore A; Shah C
Lymphat Res Biol; 2022 Dec; 20(6):618-628. PubMed ID: 35099283
[No Abstract] [Full Text] [Related]
4. Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention.
Koelmeyer LA; Gaitatzis K; Dietrich MS; Shah CS; Boyages J; McLaughlin SA; Taback B; Stolldorf DP; Elder E; Hughes TM; French JR; Ngui N; Hsu JM; Moore A; Ridner SH
Cancer; 2022 Sep; 128(18):3408-3415. PubMed ID: 35797441
[TBL] [Abstract][Full Text] [Related]
5. Correlation of Bioimpedance Spectroscopy with Risk Factors for the Development of Breast Cancer-Related Lymphedema.
Vicini F; Shah C; Whitworth P; Walker M; Shi J
Lymphat Res Biol; 2018 Dec; 16(6):533-537. PubMed ID: 30133336
[No Abstract] [Full Text] [Related]
6. The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients.
Zheng SY; Chen CY; Qi WX; Cai G; Xu C; Cai R; Qian XF; Shen KW; Cao L; Chen JY
Breast; 2023 Apr; 68():142-148. PubMed ID: 36764019
[TBL] [Abstract][Full Text] [Related]
7. Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
Kaufman DI; Shah C; Vicini FA; Rizzi M
Breast Cancer Res Treat; 2017 Dec; 166(3):809-815. PubMed ID: 28831632
[TBL] [Abstract][Full Text] [Related]
8. Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis.
Shaitelman SF; Chiang YJ; Griffin KD; DeSnyder SM; Smith BD; Schaverien MV; Woodward WA; Cormier JN
Breast Cancer Res Treat; 2017 Apr; 162(2):201-215. PubMed ID: 28012086
[TBL] [Abstract][Full Text] [Related]
9. Loco-regional therapy and the risk of breast cancer-related lymphedema: a systematic review and meta-analysis.
Lin Y; Xu Y; Wang C; Song Y; Huang X; Zhang X; Cao X; Sun Q
Breast Cancer; 2021 Nov; 28(6):1261-1272. PubMed ID: 34106427
[TBL] [Abstract][Full Text] [Related]
10. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
11. Axillary lymph node dissection can be omitted in patients with limited clinically node-positive breast cancer: a National Cancer Database analysis.
Cocco D; Shah C; Wei W; Wilkerson A; Grobmyer SR; Al-Hilli Z
Br J Surg; 2022 Nov; 109(12):1293-1299. PubMed ID: 36066266
[TBL] [Abstract][Full Text] [Related]
12. [Identification and preservation of arm lymphatics in axillary lymph node dissection to prevent arm lymphedema: a single center randomized controlled trial].
Yuan QQ; Wu GS; Hou JX; Zheng LW; Liao YQ; He YK
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):430-435. PubMed ID: 35615800
[No Abstract] [Full Text] [Related]
13. Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial.
Naoum GE; Roberts S; Brunelle CL; Shui AM; Salama L; Daniell K; Gillespie T; Bucci L; Smith BL; Ho AY; Taghian AG
J Clin Oncol; 2020 Oct; 38(29):3430-3438. PubMed ID: 32730184
[TBL] [Abstract][Full Text] [Related]
14. Timing of Lymphedema After Treatment for Breast Cancer: When Are Patients Most At Risk?
McDuff SGR; Mina AI; Brunelle CL; Salama L; Warren LEG; Abouegylah M; Swaroop M; Skolny MN; Asdourian M; Gillespie T; Daniell K; Sayegh HE; Naoum GE; Zheng H; Taghian AG
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):62-70. PubMed ID: 30165125
[TBL] [Abstract][Full Text] [Related]
15. Patterns in the Use of Axillary Operations for Patients with Node-Positive Breast Cancer After Neoadjuvant Chemotherapy: A National Cancer Database (NCDB) Analysis.
Srour MK; Tseng J; Luu M; Alban RF; Giuliano AE; Chung A
Ann Surg Oncol; 2019 Oct; 26(10):3305-3311. PubMed ID: 31342364
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer-related lymphedema after axillary lymph node dissection: does early postoperative prediction model work?
Soran A; Menekse E; Girgis M; DeGore L; Johnson R
Support Care Cancer; 2016 Mar; 24(3):1413-9. PubMed ID: 26349574
[TBL] [Abstract][Full Text] [Related]
17. A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer.
Beek MA; Gobardhan PD; Klompenhouwer EG; Menke-Pluijmers MB; Steenvoorde P; Merkus JW; Rutten HJ; Voogd AC; Luiten EJ
Eur J Surg Oncol; 2020 Jan; 46(1):59-64. PubMed ID: 31402072
[TBL] [Abstract][Full Text] [Related]
18. Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study.
Nguyen TT; Hoskin TL; Habermann EB; Cheville AL; Boughey JC
Ann Surg Oncol; 2017 Oct; 24(10):2972-2980. PubMed ID: 28766228
[TBL] [Abstract][Full Text] [Related]
19. Axillary lymph node treatment in breast cancer: an update.
Williams PA; Suggs J; Mangana SH
J Miss State Med Assoc; 2014 May; 55(5):145-7. PubMed ID: 25112128
[TBL] [Abstract][Full Text] [Related]
20. Incidence and time of occurrence of regional recurrence in stage I-II breast cancer: value of adjuvant irradiation.
Fodor J; Toth J; Major T; Polgar C; Nemeth G
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):281-7. PubMed ID: 10760420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
